secwatch.observer — SEC 8-K summary
======================================

Issuer:     InMed Pharmaceuticals Inc. (INM)
CIK:        0001728328
Form:       8-K
Filed at:   2024-12-19T23:59:59+00:00
Accession:  0001213900-24-110429
Event type: other_material
Sentiment:  neutral
Materiality: 0.50
Item codes: 5.07, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

InMed director Janet Grove fails re-election; resignation tendered per majority voting policy
--------------------------------------------------------------------------------

- Janet Grove received only 44.26% votes for (55.74% withheld); per policy she tendered resignation to Board chair.
- Nominating & Governance Committee will review whether to accept Grove's resignation; update to follow.
- Four other director nominees re-elected with >96% votes for each (Adams, Hull, Lemerond, Baldasare).
- Shareholders approved appointment of Marcum LLP (now CBIZ LLP) as independent auditor for the next year.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1728328/000121390024110429/0001213900-24-110429-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1728328/000121390024110429/ea0225311-8k_inmed.htm
  HTML page:      https://secwatch.observer/filing/0001213900-24-110429

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer